Medullary thyroid cancer with RET V804M mutation: more indolent than expected? Frisco NA, Gunn AH, Thomas SM, Stang MT, et al. Surgery 2022 Sep 20. pii: S0039-6060(22)00323.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Frisco NA, Gunn AH, Thomas SM, Stang MT, et al. Medullary thyroid cancer with RET V804M mutation: more indolent than expected? Surgery 2022 Sep 20. pii: S0039-6060(22)00323.
PMID: 36150924